ERS Webinar

View all ERS Webinar

MDR-TB guidelines: what is new on clinical management

Chair: Giovanni Battista Migliori Speaker: Payam Nahid

MDR-TB still represents a clinical and public health priority. Its treatment is long, difficult, expensive and with frequent adverse events, so that clinicians benefit from updated guidelines. Its prevention strategy largely rely on the capacity of treating correctly the existing cases of MDR-TB, on top of treating adequately new cases with a drug susceptible pattern. In March 2019 the WHO has issued its new MDR-TB guidelines, supporting full oral regimens and introducing a new classification of anti-TB drugs. ATS, ERS , IDSA and CDC are finalising new clinical guidelines which will be specifically focused on low TB incidence countries. Given the important changes the new guidelines are going to propose, this webinar will be important for all health staff involved in MDR management and control.

Educational aims

By attending the course the audience will gain important updated knowledge on the evidence-based approach to design guidelines, on the new 2019 MDR-TB treatment guidelines’ recommendations and on the role of the TB Consilia to ensure quality management of these cases.


Lecture with case presentations


  • Short description of the methodology used to design guidelines
  • What new mdr-tb guidelines are/will be available in 2019
  • Core news in the 2019 mdr-tb guidelines
  • Differences and similarities between the new guidelines
  • Presentation of a clinical case
  • Role of the tb conslium in ensuring adequate clinical management of difficult-to-treat cases

Learning outcomes

  • Describe the methodology used to design guidelines (GRADE)
  • Report what new MDR-TB guidelines are/will be available in 2019
  • Discuss the core news in the 2019 MDR-TB guidelines
  • Discuss the differences and similarities between the new guidelines
  • Understand the value of the new guidelines through the discussion of a clinical case
  • Report the role of the TB Conslium in ensuring adequate clinical management of difficult-to-treat cases

What is a webinar?

The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.

This webinar comprises 45-minute lecture followed by a 15-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls. Your answers are not evaluated but participation is mandatory to obtain the CME credits.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.

Log in guidelines

To attend the webinar you will need to log in to an Adobe Connect platform. We will send you related login information one week before the webinar is due to commence.

In order to benefit from this live experience we advise that you ensure that your equipment is compatible with the technical specifications listed here:

It is also recommended that you perform a system test.

  • Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact
  • Check Central European Time.
  • To achieve the best quality, we recommend to stop all other programmes and to avoid downloading anything from the internet during your connection to the lecture.
  • Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.

Target Audience

  • Adult Pulmonologist/Clinician
  • Medical Student
  • Nurse
  • Physician in Pulmonary Training
  • Thoracic Surgeon

Diseases / Methods

Respiratory infections
General respiratory patient care
Public health